In 2012, the small molecule VHL ligand (VHL ligand 1) has been developed to specifically interact with VHL without an inhibitory effect to the tumor suppressive function of the VHL E3 ligase (Buckley et al., 2012a,b; Galdeano et al., 2014). Here, VHL is linked to neoplasm.